SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022346
Filing Date
2017-11-07
Accepted
2017-11-07 17:24:48
Documents
52
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20170930.htm 10-Q 1600493
2 EX-31.1 tcon-ex311_20.htm EX-31.1 8874
3 EX-31.2 tcon-ex312_19.htm EX-31.2 8965
4 EX-32.1 tcon-ex321_18.htm EX-32.1 4901
5 EX-32.2 tcon-ex322_17.htm EX-32.2 4894
6 GRAPHIC g20171107003248058427.jpg GRAPHIC 42504
  Complete submission text file 0001564590-17-022346.txt   5738538

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tcon-20170930.xml EX-101.INS 1326182
8 XBRL TAXONOMY EXTENSION SCHEMA tcon-20170930.xsd EX-101.SCH 43995
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20170930_cal.xml EX-101.CAL 39104
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20170930_def.xml EX-101.DEF 116414
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20170930_lab.xml EX-101.LAB 288306
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20170930_pre.xml EX-101.PRE 212508
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 171184461
SIC: 2836 Biological Products, (No Diagnostic Substances)